Answer
The selected prolonged-release products are licensed for severe chronic pain in adults that can be adequately managed only with opioid analgesics.
Sources for this answer
- Tapentadol Aspire 250 mg prolonged-release tablets — Current selected SmPCemc · Summary of Product Characteristics
- Tapentadol Neuraxpharm 150 mg prolonged-release capsules, hard — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.